CroíValve
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
$27MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Pitching BGF? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room